Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z008867 | OT |
HCP reported vaccine was administered after temperature excursion. No other information provided. See additional AEs 02872616, 02872668, 02872694. No PQC reported. ? Names of vaccines involved (including lot/exp) PROQUAD Z008867 11/10/2026; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 08-SEP-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z008867, expiration date: 10-NOV-2026) 0.5 mL, administered by Subcutaneous route (dose not reported) as prophylaxis after temperature excursion. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date not reported). No other information provided. Additionally, it was reported that the temperature was 32 farenheit (F), with time frame 4 hours 30 minute with no previous temperature excursion. The operator of device was a healthcare professional.
sterile diluent